Get notified with the latest breaking Alzheimer's disease news
Just tell us where to send your FREE notifications.
Support Research
Welcome to ALZTalk.org!
ALZTalk.org, an Alzheimer's Social Network, provided by The Fisher Center Foundation, provides a fun, personal environment for families, friends, and medical professionals to post messages, forums, blogs, pictures, videos, chat, favorite links and gives the ability to stay connected with those in the Alzheimer's community.
The Fisher Center for Alzheimer's Research Foundation provides indepth information and Nobel Prize winning research on Alzheimer's Disease.
Enjoy your stay!
STOP Alzheimer's Now!
Our scientists have made recent advances in their research that might lead to new treatments. Now is the time! The answer could be a dollar away.
100%, yes that means every dollar until September 1st is going to groundbreaking Alzheimer’s research from a Nobel Prize winning researcher. Join our team here.
Exciting Discoveries in Alzheimer's Disease
The Fisher Center for Alzheimer’s Research Foundation primarily funds the research of Nobel laureate Dr. Paul Greengard. Dr. Greengard and his team of scientists have recently developed new technologies that will accelerate the pace of future Alzheimer’s research. Based on these new findings, we have doubled our funding commitment this year to support the promising new research initiatives that are now possible.
NAMENDA XR is a 28 mg once-daily extended-release formulation of NAMENDA. The safety and efficacy of NAMENDA XR were established in a randomized, double-blind, placebo-controlled trial of 677 outpatients already taking a cholinesterase inhibitor. The results indicate that patients treated with NAMEN
Eisai Inc. and Pfizer Inc [NYSE: PFE] announced today that the U.S. Food and Drug Administration (FDA) approved a new once-daily, higher-dose Aricept (donepezil HCl) 23 mg tablet for the treatment of moderate-to-severe Alzheimer’s disease (AD). Aricept 23 mg tablet offers another dosing option
Alzheimer's Association TrialMatch, a free service that makes it easy for people with Alzheimer's, caregivers, families and physicians to locate clinical trials based on personal criteria (diagnosis, stage of disease) and location. Right now, we are in the midst of an exciting
This is my first entry at this site. It will feel good to get some feelings down on "paper," but it won't be the same as talking about them with someone. My father was diagnosed with Alzheimer's 2 years ago and had been coping fairly well up until this past weekend. I li
